End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
215.6 MXN | +7.91% | -.--% | -0.13% |
May. 31 | SMITH & NEPHEW : EPS cut (2023: +8.0%, 2024: -16.2%) | |
May. 14 | European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading | MT |
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- For the past year, analysts have significantly revised downwards their profit estimates.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-0.13% | 10.99B | - | ||
+13.33% | 130B | A- | ||
-5.82% | 8.35B | C | ||
+43.84% | 5.67B | B+ | ||
-27.00% | 4.72B | C | ||
+7.34% | 3.42B | C- | ||
-12.25% | 2.76B | B- | ||
-14.30% | 1.92B | - | ||
-30.16% | 1.68B | C- | ||
-9.05% | 1.15B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- SN. Stock
- SN1 N Stock
- Ratings Smith & Nephew plc